Who are Cognision's investors?

Cognision's investors include Keyhorse Capital.

Cognision

1 known investors

Cognision develops an objective measurement system for evaluating patients with cognitive disorders including concussion, mTBI, and dementia, serving clinicians, pharmaceutical companies, and researchers through brain-based biomarkers and qEEG/ERP testing.

AI & Machine Learning Digital Health Medical Devices

Investors · 1

Keyhorse CapitalLexingtonvia Kelby Price · inferred

Competitors · 1

by search overlap

Cognito TX26 shared keywordsCognito Therapeutics develops Spectris, a non-invasive sensory stimulation technology platform to treat neurodegenerative diseases including Alzheimer's by improving cognitive performance. The company serves patients with neurodegenerative conditions and aims to transform disease management through clinical-to-commercial pathways in the neurological therapeutics sector.

Companies competing with Cognision for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Cognitive-focused dev Neuronetrix raises $2m - MassDevicemassdevice.com · Jul 2018

Frequently asked questions

What does Cognision do?: Cognision develops an objective measurement system for evaluating patients with cognitive disorders including concussion, mTBI, and dementia, serving clinicians, pharmaceutical companies, and researchers through brain-based biomarkers and qEEG/ERP testing.
Who are Cognision's investors?: Cognision's investors include Keyhorse Capital.